Skip to main content

Table 1 Subject Demographics and Pulmonary Function Shown here are subject demographics and lung function data

From: Peripheral blood gene expression profiles in COPD subjects

Phenotype Case ID Array ID Age Race Gender FEV1 %Pred FVC %Pred FEV1/FVC Diagnosis
Case 1 2797 987W 70 Caucasian Male 25.22 37 56 NSC Squamous
Case 2 3589 987I 59 Caucasian Female 28.12 52 44 NSC Squamous
Case 3 2224 987H 52 Caucasian Female 31.10 46 52 NSC
Case 4 1576 987U 68 Caucasian Male 36.29 75 43 Emphysema
Case 5 3660 987K 77 Caucasian Male 43.34 75 53 NSC Squamous
Case 6 2267 987N 56 Caucasian Male 46.58 67 56 NSC Squamous
Case 7 3175 987B 75 Caucasian Male 47.59 94 41 NSC Adeno
Case 8 3043 987A 61 Caucasian Male 52.12 81 59 NSC Squamous
Case 9 2336 987M 65 African-American Female 65.66* 99 51 NSC Adeno
Case 10 2195 987E 53 Caucasian Female 60.36 88 57 NSC Adeno
Case 11 2195 987F 53 Caucasian Female 60.36 88 57 NSC Adeno
Case 12 3822 987R 64 Caucasian Male 66.81 94 54 NSC Squamous
Average    62.75    45.26 74.67 51.92  
Control 1 1769 987X 50 Caucasian Female 82.69 119 75 NSC Adeno
Control 2 2563 987T 55 Caucasian Female 87.07 95 76 NSC Adeno
Control 3 3712 987Q 62 Caucasian Female 87.12 80 86 NSC Squamous
Control 4 2473 987S 77 Caucasian Female 91.53 81 82 NSC Squamous
Control 5 2254 987J 71 Caucasian Female 95.00 94 78 NSC Adeno
Control 6 3761 987O 40 Caucasian Male 95.37 101 82 Carcinoid
Control 7 3143 987C 71 Caucasian Male 103.28 115 72 NSC Adeno
Control 8 3708 987L 78 Caucasian Female 104.42 91 85 Metastatic Renal Cell Carcinoma
Control 9 3529 987D 54 Caucasian Female 105.15 116 75 Unknown
Control 10 3555 987G 55 Caucasian Male 108.49 118 79 Inflammation
Control 11 1584 987V 68 Caucasian Female 110.95 117 74 NSC Adeno
Control 12 3769 987P 78 Caucasian Male 112.01 117 78 NSC-mixed
Average    63.25    98.59 103.67 78.5